Krensavage Asset Management’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Krensavage Asset Management’s Portfolio FURX Stock Details FURX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-145,544	Closed	-$1.42M	–	24
2015 Q3	$1.42M	Hold	145,544	–	–	0.51%	22
2015 Q2	$1.42M	Hold	145,544	–	–	0.54%	22
2015 Q1	$1.42M	Hold	145,544	–	–	0.65%	23
2014 Q4	$1.42M	Buy	+145,544	New	+$1.42M	0.79%	23

Other funds holding FURX

MLICM

Metropolitan Life Insurance Company (MetLife) New York $328M AUM 9.77% 1-Year Est. Return

Krensavage Asset Management's FURX Position: Q4 2015 in Review

Krensavage Asset Management sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q4 2015, closing a stake of 145,544 shares — an estimated $1.42M sold.

Krensavage Asset Management first reported a position in FURX in Q4 2014 and held it in 4 quarters. The position peaked at $1.42M in Q3 2015. 1 fund tracked by Wall St. Rank holds FURX as of Q4 2015.

Krensavage Asset Management reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
Krensavage Asset Management sold 145,544 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015, an estimated $1.42M.
Krensavage Asset Management first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 4 quarters.
Krensavage Asset Management's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.42M in Q3 2015.
1 fund tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Krensavage Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.